MBX Biosciences, Inc. Common Stock
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MBX research report →
About the company
MBX Biosciences, Inc. is a biopharmaceutical company in its clinical development phase, dedicated to pioneering precise peptide-based therapies for endocrine and metabolic conditions. Its most advanced drug candidate, MBX 2109, is a parathyroid hormone peptide prodrug currently in Phase 2 clinical trials.
- CEO
- Peter Kent Hawryluk
- IPO
- 2000
- Employees
- 43
- HQ
- Carmel, IN, US
Price Chart
- Market Cap
- $1.94B
- P/E
- -26.27
- P/S
- 0.00
- P/B
- 6.15
- EV/EBITDA
- -21.96
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -24.50%
- ROIC
- -22.54%
- Revenue
- $0 · 0.00%
- Net Income
- $-86,971,000 · -40.45%
- EPS
- $-2.38 · -28.65%
- Op Income
- $-98,055,000
- FCF YoY
- -47.38%
- 52W High
- $58.50
- 52W Low
- $9.63
- 50D MA
- $36.48
- 200D MA
- $30.38
- Beta
- 0.16
- Avg Volume
- 762.96K
Get TickerSpark's AI analysis on MBX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 4, 26 | Mathers Edward T | other | 12,500 |
| Jun 4, 26 | Pescovitz Ora H. | other | 12,500 |
| Jun 4, 26 | Heron Patrick J | other | 12,500 |
| Jun 4, 26 | Stelzer Laurie | other | 12,500 |
| Jun 4, 26 | Hoerter Steven L. | other | 12,500 |
| Jun 4, 26 | Ryder Steven | other | 12,500 |
| Jun 4, 26 | Aynechi Tiba | other | 12,500 |
| May 8, 26 | Azoulay Salomon | other | 55,000 |
| May 8, 26 | Azoulay Salomon | other | 55,000 |
| May 8, 26 | Azoulay Salomon | other | 15,003 |
Our MBX coverage
Recent articles, reports, and earnings notes.
No research on MBX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MBX report →Similar companies
Peers in the same neighborhood.